Allergan plc and actress, model and producer Kate Bosworth today announced the launch of ACZONE (dapsone) Gel, 7.5 percent, a prescription
topical treatment for patients ages 12 and older who suffer
from acne.
Boswell, along with dermatologist Dr. Joshua Zeichner, shared her experiences with acne and steps that sufferers can take to manage the chronic skin condition.
"While one of my favorite parts of the job is being able to travel the world, my on-the-go schedule can encounter several inconsistencies, like lack of sleep or environmental changes," Boswell said. "Finding a balance with a healthy lifestyle and consistent skin care regimen has helped me tremendously. I visited my dermatologist and was prescribed ACZONE Gel, 7.5 percent to treat my acne."
While acne is usually thought of as a teenager's skin condition, adult acne is common. Approximately one in three patients seeking help with acne are age 25 or older.
"It is not uncommon for women to develop acne for the first time as an adult, in their 20s or 30s, Zeichner said. "I always remind my patients that acne is not just an issue teenagers suffer with. While there is no cure, it can be managed with the right treatment regimen."
The U.S. Food and Drug Administration approved ACZONE Gel for use as a once daily topical application in February. The clinical trial found that it was effective against whiteheads, blackheads and inflammatory acne.
"We are very fortunate to be partnering with Kate for this event to launch the new ACZONE Gel, 7.5 percent," Allergan SVP, Medical Dermatology, Jag Dosanjh said. "Through Kate's story, we hope to show acne sufferers that they are not alone with acne on their mind and encourage them to visit a dermatologist to find the right treatment option and help have less acne to think about."
Alerts Sign-up